Shenwan Hongyuan Group (06806): 26 Shen Zheng 01 completes payment of principal and interest and is delisted.
Shenwan Hongyuan (06806) announced that its subsidiary, Shenwan Hongyuan Securities Co., Ltd., will issue non-publicly offered corporate bonds (Phase 1) for professional investors on January 28, 2026. The issuance scale is RMB 1.3 billion, with a term of 189 days and a coupon rate of 1.69%. The bond code is 134833, and the bond abbreviation is 26 Shenzheng 01.
Shenwan Hongyuan Group (06806) announced that its subsidiary Shenwan Hongyuan Group Securities Co., Ltd. will issue non-publicly offered corporate bonds for professional investors (Phase I) on January 28, 2026. The issuance scale is RMB 1.3 billion, with a term of 189 days and a coupon rate of 1.69%. The bond code is 134833, and the bond abbreviation is 26 Shen Zheng 01.
The maturity date for this bond is August 5, 2026, and the delisting date is also August 5, 2026. Shenwan Hongyuan Group Securities Co., Ltd. has completed the principal and interest payment for this bond in accordance with the relevant provisions of the "Shenwan Hongyuan Group Securities Co., Ltd. 2026 Non-Publicly Offered Corporate Bonds for Professional Investors (Phase I) Fundraising Memorandum" and has proceeded with delisting.
Related Articles
XIAOMI-W (01810) invested HKD 49.9504 million on August 6th to repurchase 1.862 million shares.
HAOHAI BIOTEC (06826) subsidiary has obtained a medical device registration certificate for its trifocal toric intraocular lens product.
HENG TAI (00197): Chan Wai Ying has been appointed as an independent non-executive director.
XIAOMI-W (01810) invested HKD 49.9504 million on August 6th to repurchase 1.862 million shares.
HAOHAI BIOTEC (06826) subsidiary has obtained a medical device registration certificate for its trifocal toric intraocular lens product.
HENG TAI (00197): Chan Wai Ying has been appointed as an independent non-executive director.
RECOMMEND
